Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Trial Cleared for Lab-Grown Replacement Knee Cartilage

Knee joint X-ray

A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage

Cancer Immunotherapy Biotech Issues $80M IPO

Wall Street sign

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

One-Time Crispr HIV Therapy Given Fast-Track Status

T-cell infected by HIV

A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status

Low-Dose Oral Film Reduces Mental Disorder Agitation

Depression

Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia. . . . → Read More: Low-Dose Oral Film Reduces Mental Disorder Agitation

Brain-Computer Device Company Gains $33M in Early Funds

Electrode microarray illustration

A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round. . . . → Read More: Brain-Computer Device Company Gains $33M in Early Funds

Real World Evidence Shown to Emulate Some Clinical Trials

Data pointing finger

A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials

Biotech Gains $53.7M Infectious Disease Test Award

SARS-Cov-2 virus

A maker of diagnostics for infectious diseases is receiving a $53.7 million contract to develop and validate reliable home molecular tests for Covid-19 and flu infections. . . . → Read More: Biotech Gains $53.7M Infectious Disease Test Award

Biotech Group Blasts Reproductive Drug Ruling

Mifeprex boxes

A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling

Trial Okayed for Glaucoma Treatment Implant

Fundus photograph

A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma. . . . → Read More: Trial Okayed for Glaucoma Treatment Implant

Trial to Test Low-Dose Psilocybin for Mental Distress

Psilocybe aztecorum

A developer of mental health therapies from psychedelic compounds says it received FDA clearance for a clinical trial testing low doses of psilocybin. . . . → Read More: Trial to Test Low-Dose Psilocybin for Mental Distress